217 related articles for article (PubMed ID: 27429296)
1. Sustained-release hydrogels of topotecan for retinoblastoma.
Taich P; Moretton MA; Del Sole MJ; Winter U; Bernabeu E; Croxatto JO; Oppezzo J; Williams G; Chantada GL; Chiappetta DA; Schaiquevich P
Colloids Surf B Biointerfaces; 2016 Oct; 146():624-31. PubMed ID: 27429296
[TBL] [Abstract][Full Text] [Related]
2. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
3. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model.
Hobzova R; Kodetova M; Pochop P; Uhlik J; Dunovska K; Svojgr K; Hrabeta J; Feriancikova B; Cocarta AI; Sirc J
Int J Pharm; 2021 Sep; 606():120832. PubMed ID: 34175379
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium.
Luo Z; Jin L; Xu L; Zhang ZL; Yu J; Shi S; Li X; Chen H
Drug Deliv; 2016; 23(1):63-8. PubMed ID: 24758189
[TBL] [Abstract][Full Text] [Related]
5. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment.
Wang Q; Sun C; Xu B; Tu J; Shen Y
Drug Deliv; 2018 Nov; 25(1):59-69. PubMed ID: 29228826
[TBL] [Abstract][Full Text] [Related]
7. Hydrogel implants for transscleral drug delivery for retinoblastoma treatment.
Cocarta AI; Hobzova R; Sirc J; Cerna T; Hrabeta J; Svojgr K; Pochop P; Kodetova M; Jedelska J; Bakowsky U; Uhlik J
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109799. PubMed ID: 31349439
[TBL] [Abstract][Full Text] [Related]
8. Injectable supramolecular hydrogel from insulin-loaded triblock PCL-PEG-PCL copolymer and γ-cyclodextrin with sustained-release property.
Khodaverdi E; Heidari Z; Tabassi SA; Tafaghodi M; Alibolandi M; Tekie FS; Khameneh B; Hadizadeh F
AAPS PharmSciTech; 2015 Feb; 16(1):140-9. PubMed ID: 25224297
[TBL] [Abstract][Full Text] [Related]
9. Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: alternative retinoblastoma treatment.
Darsova D; Pochop P; Uhlik J; Klapkova E; Tesfaye H; Kodetova D; Lestak J; Malis J; Vajner L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Dec; 156(4):318-23. PubMed ID: 22660213
[TBL] [Abstract][Full Text] [Related]
10. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
[TBL] [Abstract][Full Text] [Related]
11. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
Xu S; Wang W; Li X; Liu J; Dong A; Deng L
Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
[TBL] [Abstract][Full Text] [Related]
12. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A
Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677
[TBL] [Abstract][Full Text] [Related]
13. Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).
Sun S; Li J; Li X; Lan B; Zhou S; Meng Y; Cheng L
Acta Biomater; 2016 Jun; 37():143-54. PubMed ID: 27071973
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the fraction of the active form of an antitumor drug topotecan via an injectable hydrogel.
Chang G; Ci T; Yu L; Ding J
J Control Release; 2011 Nov; 156(1):21-7. PubMed ID: 21777632
[TBL] [Abstract][Full Text] [Related]
15. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
[TBL] [Abstract][Full Text] [Related]
16. Temperature/pH Responsive Hydrogels Based on Poly(ethylene glycol) and Functionalized Poly(e-caprolactone) Block Copolymers for Controlled Delivery of Macromolecules.
Nikouei NS; Ghasemi N; Lavasanifar A
Pharm Res; 2016 Feb; 33(2):358-66. PubMed ID: 26415645
[TBL] [Abstract][Full Text] [Related]
17. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel: part 1--Synthesis, characterization, and acute toxicity evaluation.
Gong CY; Shi S; Dong PW; Yang B; Qi XR; Guo G; Gu YC; Zhao X; Wei YQ; Qian ZY
J Pharm Sci; 2009 Dec; 98(12):4684-94. PubMed ID: 19367619
[TBL] [Abstract][Full Text] [Related]
19. Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel.
Gou M; Gong C; Zhang J; Wang X; Wang X; Gu Y; Guo G; Chen L; Luo F; Zhao X; Wei Y; Qian Z
J Biomed Mater Res A; 2010 Apr; 93(1):219-26. PubMed ID: 19557789
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel.
Gong C; Shi S; Dong P; Kan B; Gou M; Wang X; Li X; Luo F; Zhao X; Wei Y; Qian Z
Int J Pharm; 2009 Jan; 365(1-2):89-99. PubMed ID: 18793709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
